<DOC>
	<DOCNO>NCT02042742</DOCNO>
	<brief_summary>A crossover trial carry healthy volunteer age 45-70 year BMI &lt; 30 kg/m2 . Subjects consume Antioxidant Supplement ( AS ) contain 65 mg punicalagin mix 3.3 mg hydroxytyrosol 3 time daily Control Supplement ( CS ) maltodextrin 8 wk phase 4-wk rest period . Supplementation order randomly assign consumption derivative product punicalagin and/or hydroxytyrosol restrict . The endothelial function parameter ( brachial artery flow-mediated dilation ( FMD ) , biochemical marker ) , inflammatory marker nutritional status evaluate phase . Previously pilot study complete placebo ( n=30 ) determinate effective dose Functional Supplement .</brief_summary>
	<brief_title>Punicalagin Hydroxytyrosol Mixture Different Inflammatory Markers</brief_title>
	<detailed_description />
	<mesh_term>3,4-dihydroxyphenylethanol</mesh_term>
	<mesh_term>Phenylethyl Alcohol</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>Men woman 45 75 year old ; Signed informed consent Individuals cardiovascular risk factor drug treatment ( dyslipidemia , hypertension , Diabetes Mellitus ) ; Individuals Metabolic Syndrome ; Individuals familiar background premature cardiovascular disease ; Individuals BMI ≥ 30 kg/m2 ; Women still maintain menstrual cycle ; Individuals increase alcohol consumption 30g/day ; Individuals stop smoke next 20 week ( study ) ; Individuals consume antioxidant supplement , drug , ω3 supplement , vitamin , mineral , prebiotics or/and probiotic ; Women consume oral contraceptive ; Individuals mental disease low cognitive function ; Individuals severe disease ( hepatic , kidney , cancer… ) ; Individuals drug supplement consumption weight lose ; Pregnant woman lactate ; Individuals intensive physical activity ; Individuals physical problem comply recommendation physical activity diet general recommendation .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Cross-over study</keyword>
	<keyword>Antioxidants</keyword>
	<keyword>Hydroxytyrosol</keyword>
	<keyword>Punicalagin</keyword>
	<keyword>Treatment outcome</keyword>
	<keyword>Inflammatory marker</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>Humans</keyword>
	<keyword>Adults</keyword>
	<keyword>volunteer</keyword>
</DOC>